Fungal Infections in Intensive Care Medicine

Dear Colleagues,

Advances in the diagnosis and management of a variety of conditions coupled with improvements in the care of critically ill patients have revealed new challenges. One of these challenges is the increased significance of fungal infections in critically ill patients. These include emerging risk factors, such as patients with respiratory viral illnesses, patients taking immunosuppressants or undergoing immunomodulatory treatments, and those with chronic illnesses such as COPD and liver disease. Fungal infections in critically ill patients include candida, aspergillus, PJP, mucor, and endemic fungi. Significant advances in the diagnosis and management of fungal infections correspond to these risk factors. However, there are obstacles to using antifungal agents in critically ill patients due to organ dysfunction, adverse effects, drug interactions, and resistance.

Clinicians and researchers are encouraged to submit papers related to fungal infections in critically ill patients with a focus on the following topics:

• The spectrum of fungal infections (in general or specific fungi);
• The risk factors of fungal infections;
• The challenges in the diagnosis of fungal infections;
• Antifungal therapy—including its effectiveness, drug–drug interactions, adverse reactions, drug resistance, and newer agents;
• The outcomes of fungal infections;
• Future directions.

Prof. Dr. Ayman O. Soubani
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Fungi is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• fungal infections
• critically ill
• ICU
• Candida spp.
• Aspergillus spp.
• PJP
• Mucor spp.
• antifungal therapy
• antifungal resistance
• new antifungal agents